Back to search results

Moms@Home: Improving Blood Pressure Management in Pregnancy

This study is testing a new mobile app called Moms@Home to help pregnant women manage their blood pressure. If you have high blood pressure during pregnancy (gestational hypertension) or chronic high blood pressure, and are between 18 and 50 years old, you might be able to join. The Moms@Home app uses storytelling videos and a dashboard to help you track your blood pressure daily and remember medications. Researchers want to see if using Moms@Home helps women stick to their blood pressure monitoring schedule better than using a paper journal. The study is currently unclear on its recruitment status and plans to enroll 100 participants.

Study design
This is a pilot randomized controlled trial, meaning participants will be randomly assigned to either use the Moms@Home app or a paper journal. It plans to enroll 100 pregnant women.
What's involved
Participants will use either the Moms@Home mobile health app or a paper journal daily for home-based blood pressure monitoring and tracking symptoms/medications. This will be done for 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The main study goals are measured at 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06835959

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

Recruiting
NAAges 18–50InterventionalPrevention
University of Massachusetts, Worcester
~100 participants
Updated 2026-06-16 on ClinicalTrials.gov
What's tested:Moms@HomeEnhanced Standard of Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Home Blood Pressure Monitoring Adherence
Measured over 8 weeks
+2 more outcomes measured

Conditions

Hypertension in Pregnancy
Chronic Hypertension
Gestational Hypertension

Explore related trials

Gestational HypertensionHypertension

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Lara Kovell, MD,MSc · PRINCIPAL_INVESTIGATOR · University of Massachusetts Medical School, Worcester

Who to contact

Lara Kovell, MD,MSc
[email protected]
(508) 856-2772
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18-50
English or Spanish speaking
A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age)
Singleton or multiple gestation pregnancy,
A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts
Willing to share home blood pressure monitoring data
Comfortable with the use of smartphones and mobile apps

Exclusion

Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg)
Current diagnosis of preeclampsia
Active substance use
Serious physical illness (e.g., unable to interact with a smart device)
Enrolled in another home blood pressure monitoring program
Excluded from study participation by their provider
Inability to provide informed consent
Prisoners/institutionalized individuals

What this trial measures

  • Home Blood Pressure Monitoring Adherence8 weeks

    Home blood pressure monitoring (HBPM) adherence is defined as performing HBPM measures ≥3 out of 7 days/week

  • Feasibility of the Moms@Home intervention8 weeks

    Among the participants in the intervention group, the feasibility of the Moms@Home intervention will be assessed through a post-intervention survey using a 5-point Likert scale, with questions on the value and overall satisfaction with the mobile intervention app. On a numeric scale, number of screened and eligible participants and the number/reason(s) for declining participation or withdrawal will be tracked.

  • Acceptability8 weeks

    Acceptability will be assessed using the System Usability Scale (SUS) and the perceived impact section of the End-user Mobile Application Rating Scale (uMARS). These are both validated measures of the usability/quality of mobile health apps. SUS is scored on a 0-100 scale, a higher score meaning better usability. The uMARS is scored on a 5-point Likert scale, with the total score calculated by averaging the scores across the items within the perceived impact subscale.